Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS
· Delayed Price · Currency is USD
0.2328
-0.0008 (-0.33%)
At close: Dec 5, 2025
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $363.73 million as of December 5, 2025. Its market cap has increased by 1.37% in one year.
Market Cap
363.73M
Enterprise Value
449.62M
Revenue
937.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 363.73M, an increase of 3,435.06%. That is a compound annual growth rate of 16.02%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 131.71M |